Cell Cycle Checkpoints/genetics; Cell Differentiation/genetics; Genes, Tumor Suppressor; MicroRNAs/metabolism; Neuroblastoma/genetics; Neuroblastoma/pathology; 3' Untranslated Regions/genetics; Apoptosis/genetics; Base Sequence; Cell Proliferation; Cell Survival/genetics; Cyclin-Dependent Kinase 6/metabolism; Down-Regulation/genetics; Gene Expression Regulation, Neoplastic; Humans; Lymphoid Enhancer-Binding Factor 1/metabolism; MicroRNAs/genetics; Models, Biological; Molecular Sequence Data; Neoplasm Proteins/metabolism; RNA, Messenger/genetics; RNA, Messenger/metabolism; Reproducibility of Results; Survival Analysis

13-cis retinoic acid; Bio-control; Bio-miR-449a; CASP2; CCNE2; CDC25A; CDK6; Caspase 2; Cyclin E2; FDR; FLOT2; Flotillin 2; GAP43; GAPDH; HDAC1; LEF1; MFAP4; Oligo; PKP4; RA; STMN1; TSEN15; biotinylated control oligonucleotides; biotinylated miR-449a mimic; cell cycle arrest; cell division cycle 25A; cyclin-dependent kinase 6; differentiation; differentiation therapy; false discovery rate; glyceraldehyde-3-phosphate dehydrogenase; growth associated protein 43; histone deacetylase 1; lymphoid enhancer-binding factor 1; miR-449a; miRNA; microRNA; microRNA-449a; microfibril-associated protein 4; neuroblastoma; oligonucleotides; plakophilin 4; stathmin 1; tRNA splicing endonuclease 15 homolog